Volume Alert: Immunocor sinks on FDA action (BLUD)

Posted in General 
June 26th, 2009

Immunocor Inc. (Nasdaq: BLUD) shares are down about 27% near $11.83 at the market’s open, afer the company said the FDA plans to revoke the company’s biologics license with respect to its Reagent Red Blood Cells and Anti-E Blood Grouping Reagent product. The company has 10 working days to respond to the FDA’s administrative action and 30 days to submit a remediation plan.

See BioHealthInvestor.com for full details.

Comments are closed

-->